Education
About Us
Working with TipRanks
Follow Us
Elevance Health (ELV)
NYSE:ELV
ELV Stock Chart & Stats
$327.50
<$0.01(<0.01%)
At close: 4:00 PM EST
$327.50
<$0.01(<0.01%)
Day’s Range― - ―
52-Week Range$273.71 - $458.75
Previous CloseN/A
Volume477.50K
Average Volume (3M)1.60M
Market Cap
$71.87B
Enterprise Value$94.69B
Total Cash (Recent Filing)$9.49B
Total Debt (Recent Filing)$32.05B
Price to Earnings (P/E)13.0
Beta0.27
Next Earnings
Apr 22, 2026EPS Estimate
10.58Next Dividend Ex-DateN/A
Dividend Yield1.99%
Share Statistics
EPS (TTM)3.33
Shares Outstanding220,704,670
10 Day Avg. Volume2,555,260
30 Day Avg. Volume1,595,019
Financial Highlights & Ratios
PEG Ratio-5.63
Price to Book (P/B)1.77
Price to Sales (P/S)0.39
P/FCF Ratio24.50
Enterprise Value/Market Cap1.32
Enterprise Value/Revenue0.48
Enterprise Value/Gross Profit1.86
Enterprise Value/Ebitda9.80
Forecast
1Y Price Target
$389.07Price Target Upside18.80% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
EPS Forecast (FY)26.12
Revenue Forecast (FY)$194.82B
Bulls Say, Bears Say
Bulls Say
Carelon Investment UpsideRising investments in Carelon coupled with strong external business growth point to a future earnings contribution that could offset member-related headwinds.
Conservative Guidance PotentialConservatively framed earnings guidance establishes a low performance baseline that analysts say could enable upside surprises if margin trends improve.
Resilient Business MixExposure to more stable segments like non-exchange commercial lines, Medicare Advantage, and prescription drug benefits provides revenue stability and positions the company favorably versus peers.
Bears Say
Margin Compression And Valuation ImpactMargin compression in parts of the business and reductions in long-term margin targets have led analysts to apply lower valuation multiples, reducing long-term earnings support.
Medicaid And Exchange HeadwindsA shrinking Medicaid population and potential exchange disenrollment tied to subsidy shifts are likely to weaken the risk pool and pressure near-term profitability.
Medicare Advantage Reimbursement And Membership RiskDeclining Medicare Advantage reimbursement rates and anticipated membership declines pose a material downside risk to revenue and margins.
Elevance Health News
ELV FAQ
What was Elevance Health’s price range in the past 12 months?
Elevance Health lowest stock price was $273.71 and its highest was $458.75 in the past 12 months.
What is Elevance Health’s market cap?
Elevance Health’s market cap is $71.87B.
When is Elevance Health’s upcoming earnings report date?
Elevance Health’s upcoming earnings report date is Apr 22, 2026 which is in 69 days.
How were Elevance Health’s earnings last quarter?
Elevance Health released its earnings results on Jan 28, 2026. The company reported $3.33 earnings per share for the quarter, beating the consensus estimate of $3.096 by $0.234.
Is Elevance Health overvalued?
According to Wall Street analysts Elevance Health’s price is currently Undervalued.
Does Elevance Health pay dividends?
Elevance Health pays a Quarterly dividend of $1.71 which represents an annual dividend yield of 1.99%. See more information on Elevance Health dividends here
What is Elevance Health’s EPS estimate?
Elevance Health’s EPS estimate is 10.58.
How many shares outstanding does Elevance Health have?
Elevance Health has 220,704,670 shares outstanding.
What happened to Elevance Health’s price movement after its last earnings report?
Elevance Health reported an EPS of $3.33 in its last earnings report, beating expectations of $3.096. Following the earnings report the stock price went up 5.862%.
Which hedge fund is a major shareholder of Elevance Health?
Currently, no hedge funds are holding shares in ELV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Elevance Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$389.07 (18.80% Upside)
$389.07 (18.80% Upside)
Blogger Sentiment
Bullish
ELV Sentiment 92%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 1.6M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 6.8%
Last 30 Days ▼ 6.8%
News Sentiment
Very Bullish
Bullish news 80%
Bearish news 20%
Bearish news 20%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-14.71%
12-Months-Change
Fundamentals
Return on Equity
13.29%
Trailing 12-Months
Asset Growth
3.94%
Trailing 12-Months
Company Description
Elevance Health
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
ELV Company Deck
ELV Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call balanced significant near-term challenges—notably membership declines (Medicaid and Medicare), elevated cost trends, a negative Medicaid margin expectation for 2026, and a lower 2026 EPS baseline versus 2025—with several constructive positives: strong Q4 revenue, Carillon growth and external demand, disciplined pricing and portfolio repositioning, targeted investments in analytics and care management, healthy ASO sales momentum, and a clear plan to return to at least 12% EPS growth in 2027. Management emphasized prudent assumptions and execution, but material near-term headwinds and margin recalibrations reduce upside in 2026.View all ELV earnings summariesELV Stock 12 Month Forecast
Average Price Target
$389.07
▲(18.80% Upside)
Technical Analysis
Ownership Overview
0.14% Insiders
27.13% Mutual Funds
0.64% Other Institutional Investors
48.97% Public Companies and Individual Investors